210 related articles for article (PubMed ID: 20545943)
1. Functional basis for complement evasion by staphylococcal superantigen-like 7.
Bestebroer J; Aerts PC; Rooijakkers SH; Pandey MK; Köhl J; van Strijp JA; de Haas CJ
Cell Microbiol; 2010 Oct; 12(10):1506-16. PubMed ID: 20545943
[TBL] [Abstract][Full Text] [Related]
2. Full functional activity of SSL7 requires binding of both complement C5 and IgA.
Lorenz N; Clow F; Radcliff FJ; Fraser JD
Immunol Cell Biol; 2013 Aug; 91(7):469-76. PubMed ID: 23797068
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
Laursen NS; Gordon N; Hermans S; Lorenz N; Jackson N; Wines B; Spillner E; Christensen JB; Jensen M; Fredslund F; Bjerre M; Sottrup-Jensen L; Fraser JD; Andersen GR
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3681-6. PubMed ID: 20133685
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Ramsland PA; Willoughby N; Trist HM; Farrugia W; Hogarth PM; Fraser JD; Wines BD
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15051-6. PubMed ID: 17848512
[TBL] [Abstract][Full Text] [Related]
5. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.
Li Y; Clow F; Fraser JD; Lin F
J Mol Med (Berl); 2018 Sep; 96(9):965-974. PubMed ID: 30066197
[TBL] [Abstract][Full Text] [Related]
7. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
Wines BD; Willoughby N; Fraser JD; Hogarth PM
J Biol Chem; 2006 Jan; 281(3):1389-93. PubMed ID: 16293625
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.
Wines BD; Ramsland PA; Trist HM; Gardam S; Brink R; Fraser JD; Hogarth PM
J Biol Chem; 2011 Sep; 286(38):33118-24. PubMed ID: 21784854
[TBL] [Abstract][Full Text] [Related]
9. Identification of Set11 from Staphylococcus aureus Mu50 strain as a ortholog of SSL7 via bioinformatic analysis and determination of its possible targets from human serum using CNBr-pull down assays.
Li Y; Chen X; Jia N; Zhang X; Zang J
Biotechnol Lett; 2017 Sep; 39(9):1413-1423. PubMed ID: 28653102
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.
Zhao Y; van Kessel KPM; de Haas CJC; Rogers MRC; van Strijp JAG; Haas PA
Cell Microbiol; 2018 Nov; 20(11):e12941. PubMed ID: 30098280
[TBL] [Abstract][Full Text] [Related]
12. The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo.
Koymans KJ; Goldmann O; Karlsson CAQ; Sital W; Thänert R; Bisschop A; Vrieling M; Malmström J; van Kessel KPM; de Haas CJC; van Strijp JAG; Medina E
J Innate Immun; 2017; 9(6):561-573. PubMed ID: 28858870
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.
Laarman AJ; Ruyken M; Malone CL; van Strijp JA; Horswill AR; Rooijakkers SH
J Immunol; 2011 Jun; 186(11):6445-53. PubMed ID: 21502375
[TBL] [Abstract][Full Text] [Related]
14. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
15. Immune evasion by staphylococci.
Foster TJ
Nat Rev Microbiol; 2005 Dec; 3(12):948-58. PubMed ID: 16322743
[TBL] [Abstract][Full Text] [Related]
16. [Modulation of Host Immune System by Staphylococcal Superantigen-like (SSL) Proteins].
Tsuji T
Yakugaku Zasshi; 2021; 141(4):579-589. PubMed ID: 33790123
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.
Jongerius I; von Köckritz-Blickwede M; Horsburgh MJ; Ruyken M; Nizet V; Rooijakkers SH
J Innate Immun; 2012; 4(3):301-11. PubMed ID: 22327617
[TBL] [Abstract][Full Text] [Related]
18. Recurrent infections and immune evasion strategies of Staphylococcus aureus.
Kim HK; Thammavongsa V; Schneewind O; Missiakas D
Curr Opin Microbiol; 2012 Feb; 15(1):92-9. PubMed ID: 22088393
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal enterotoxin-like X (SElX) is a unique superantigen with functional features of two major families of staphylococcal virulence factors.
Langley RJ; Ting YT; Clow F; Young PG; Radcliff FJ; Choi JM; Sequeira RP; Holtfreter S; Baker H; Fraser JD
PLoS Pathog; 2017 Sep; 13(9):e1006549. PubMed ID: 28880913
[TBL] [Abstract][Full Text] [Related]
20. Immune Evasion by
de Jong NWM; van Kessel KPM; van Strijp JAG
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30927347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
